Our formulation development team adds 35+ years of collective experience in the field of pharmaceutical and biological product development; Partnering with government bodies, universities, key opinion leaders in the industry, small to big biotech companies with a simple yet meaningful goal to progress new chemical entities to clinical/ commercial phase to help improve the Quality of Life (QoL) of patients. Our team offers end-to-end services and tailor the product development that fit-for-purposes.
Having extensive working experience developing NDAs (both 505(b)(1)s and 505(b)(2)s), ANDAs, and biosimilars – our team offers services in both sterile and non-sterile product development as well as process development/ optimization. We work with a variety of molecules with different therapeutic values and our goal is to help with unmet medical needs.
